Medicarecard.com Medicare Providers Researchers create comprehensive collection of approved drugs to identify new therapies for rare and neglected diseases

Researchers create comprehensive collection of approved drugs to identify new therapies for rare and neglected diseases

Researchers have begun screening the first definitive collection of thousands of approved drugs for clinical use against rare and neglected diseases. They are hunting for additional uses of the drugs hoping to find off-label therapies, for some of the 6,000 rare diseases that afflict 25 million Americans. The effort is coordinated by the National Institutes of Health’s Chemical Genomics Center (NCGC).